TransMedics (TMDX) stock price, revenue, and financials

TransMedics market cap is $748.9 m, and annual revenue was $25.64 m in FY 2020

$748.9 M

TMDX Mkt cap, 12-Nov-2021

$7.1 M

TransMedics Revenue Q1, 2021
TransMedics Gross profit (Q1, 2021)4.8 M
TransMedics Gross profit margin (Q1, 2021), %68.2%
TransMedics Net income (Q1, 2021)-7.9 M
TransMedics EBIT (Q1, 2021)-6.5 M
TransMedics Cash, 31-Mar-202126.7 M
TransMedics EV757 M
Get notified regarding key financial metrics and revenue changes at TransMedicsLearn more
Banner background

TransMedics Revenue

TransMedics revenue was $25.64 m in FY, 2020

Embed Graph

TransMedics Revenue Breakdown

Embed Graph

TransMedics revenue breakdown by business segment: 39.0% from OCS Lung net revenue, 45.8% from OCS Heart net revenue and 15.2% from OCS Liver net revenue

TransMedics revenue breakdown by geographic segment: 50.3% from United States and 49.7% from Outside the U.S.

TransMedics Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

6.2m7.7m13.0m23.6m25.6m

Revenue growth, %

24%69%

Cost of goods sold

5.4m5.5m7.3m9.7m9.0m

Gross profit

766.0k2.1m5.7m13.9m16.6m

Gross profit Margin, %

12%28%44%59%65%

R&D expense

15.6m15.0m13.7m19.9m18.8m

General and administrative expense

8.1m7.6m12.3m23.6m24.2m

Operating expense total

23.8m22.6m26.0m43.5m43.0m

EBIT

(23.0m)(20.4m)(20.2m)(29.6m)(26.4m)

EBIT margin, %

(370%)(266%)(155%)(125%)(103%)

Interest expense

979.0k1.1m2.7m

Pre tax profit

(24.1m)(20.8m)(23.7m)(33.5m)(28.7m)

Income tax expense

32.0k41.0k32.0k

Net Income

(24.1m)(20.8m)(23.8m)(33.5m)(28.7m)

TransMedics Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

11.9m20.2m20.1m24.6m

Accounts Receivable

925.0k3.4m6.6m6.9m

Prepaid Expenses

477.0k1.8m1.5m2.3m

Inventories

8.0m9.3m11.2m11.9m

Current Assets

34.0m34.8m100.0m146.8m

PP&E

2.5m3.5m4.8m4.8m

Total Assets

37.0m42.2m105.3m152.0m

Accounts Payable

3.5m4.7m7.2m1.2m

Short-term debt

1.8m

Current Liabilities

10.9m12.6m16.1m11.9m

Long-term debt

6.8m33.7m34.1m34.7m

Total Debt

8.7m33.7m34.1m34.7m

Total Liabilities

19.2m47.9m50.7m48.1m

Common Stock

1.0k1.0k502.2m

Preferred Stock

186.5m186.5m

Additional Paid-in Capital

143.6m143.8m

Retained Earnings

(312.2m)(335.9m)(369.5m)(398.2m)

Total Equity

17.8m(5.7m)54.6m103.9m

Financial Leverage

2.1 x-7.4 x1.9 x1.5 x

TransMedics Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(24.1m)(20.8m)(23.8m)(33.5m)(28.7m)

Depreciation and Amortization

426.0k630.0k769.0k1.2m

Accounts Receivable

(758.0k)454.0k(2.5m)(3.2m)

Inventories

(1.6m)(2.5m)(2.7m)(4.1m)

Accounts Payable

1.1m(735.0k)164.0k3.4m

Cash From Operating Activities

(24.1m)(23.1m)(26.0m)(32.3m)

Purchases of PP&E

(1.5m)(263.0k)(418.0k)(165.0k)

Cash From Investing Activities

(39.7m)24.9m12.3m(60.5m)

Long-term Borrowings

(9.1m)

Cash From Financing Activities

63.5m3.0k22.1m92.7m

Net Change in Cash

(243.0k)2.1m8.3m(149.0k)

Interest Paid

825.0k823.0k2.4m3.9m

TransMedics Ratios

USDFY, 2016

TransMedics Employee Rating

3.431 votes
Culture & Values
3.3
Work/Life Balance
3.7
Senior Management
3.1
Salary & Benefits
3.8
Career Opportunities
3.3
Source